Severity
Moderate
FDA Drug recall · Reported June 8, 2016
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services recalled Ceftriaxone 2 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Me… - a moderate-severity action.
Ceftriaxone 2 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Me… was recalled by Baptist Health Medical Towers Pharmacy and Infusion Services in June 8, 2016. Reason: Lack of Sterility Assurance. Check the official notice for the remedy. Verify recall #D-0917-2016 with the FDA Drug before acting.
The recall
Baptist Health Medical Towers Pharmacy and Infusion Services issued this moderate-severity FDA Drug recall-Lack of Sterility Assurance.
Sourced from official FDA Drug enforcement records. Verify recall #D-0917-2016 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0917-2016) was formally reported on June 8, 2016, with the manufacturer initiating the action on April 18, 2016. It is classified under Moderate severity (Class II), with a current status of Terminated. Baptist Health Medical Towers Pharmacy and Infusion Services is listed as the recalling firm, operating out of Little Rock, AR. Federal records list the affected scope as 16 bags.
The documented reason for this recall is: Lack of Sterility Assurance Distribution data in the federal record shows the product reached: Arkansas. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
16 bags
Related Recalls
6
0 from same agency
Ceftriaxone 2 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR
Lack of Sterility Assurance
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0917-2016 |
| Date reported | June 8, 2016 |
| Date initiated | April 18, 2016 |
| Recalling firm | Baptist Health Medical Towers Pharmacy and Infusion Services |
| Firm location | Little Rock, AR |
| Affected scope | 16 bags |
| Distribution | Arkansas |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 8, 2016. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.